- Home
- BRTX vs SMSI Comparison
BRTX vs SMSI Comparison
Compare BRTX & SMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- SMSI
- Stock Information
- Founded
- BRTX 1997
- SMSI 1982
- Country
- BRTX United States
- SMSI United States
- Employees
- BRTX N/A
- SMSI N/A
- Industry
- BRTX Managed Health Care
- SMSI Computer Software: Prepackaged Software
- Sector
- BRTX Health Care
- SMSI Technology
- Exchange
- BRTX Nasdaq
- SMSI Nasdaq
- Market Cap
- BRTX 12.5M
- SMSI 14.3M
- IPO Year
- BRTX N/A
- SMSI 1995
- Fundamental
- Price
- BRTX $1.84
- SMSI $0.73
- Analyst Decision
- BRTX
- SMSI Strong Buy
- Analyst Count
- BRTX 0
- SMSI 1
- Target Price
- BRTX N/A
- SMSI $5.00
- AVG Volume (30 Days)
- BRTX 88.0K
- SMSI 204.7K
- Earning Date
- BRTX 08-12-2025
- SMSI 08-06-2025
- Dividend Yield
- BRTX N/A
- SMSI N/A
- EPS Growth
- BRTX N/A
- SMSI N/A
- EPS
- BRTX N/A
- SMSI N/A
- Revenue
- BRTX $605,200.00
- SMSI $18,658,000.00
- Revenue This Year
- BRTX $232.67
- SMSI $0.03
- Revenue Next Year
- BRTX $52.92
- SMSI $52.29
- P/E Ratio
- BRTX N/A
- SMSI N/A
- Revenue Growth
- BRTX 247.62
- SMSI N/A
- 52 Week Low
- BRTX $1.21
- SMSI $0.52
- 52 Week High
- BRTX $2.55
- SMSI $1.95
- Technical
- Relative Strength Index (RSI)
- BRTX 72.78
- SMSI 49.24
- Support Level
- BRTX $1.51
- SMSI $0.66
- Resistance Level
- BRTX $1.56
- SMSI $0.77
- Average True Range (ATR)
- BRTX 0.08
- SMSI 0.04
- MACD
- BRTX 0.04
- SMSI 0.01
- Stochastic Oscillator
- BRTX 89.91
- SMSI 66.67
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.